Asthma und Chronisch-obstruktive Lungenerkrankung
- 24 February 2026
- book chapter
- Published by Springer Nature
- p. 659-676
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysisCochrane Database of Systematic Reviews, 2023
- Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2023
- Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and childrenCochrane Database of Systematic Reviews, 2022
- Anti-IL-5 therapies for asthmaCochrane Database of Systematic Reviews, 2022
- Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for people with asthmaCochrane Database of Systematic Reviews, 2021
- Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthmaCochrane Database of Systematic Reviews, 2021
- Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse eventsCochrane Database of Systematic Reviews, 2021
- Anti-IL-5 therapies for chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2020
- Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary diseaseCochrane Database of Systematic Reviews, 2020
- Omalizumab for asthma in adults and childrenCochrane Database of Systematic Reviews, 2014